Cite
HARVARD Citation
Adhikari, P. et al. (n.d.). Efficacy of Favipiravir in treatment of mild & moderate COVID-19 infection in Nepal: a multi-center, randomized, open-labelled, phase III clinical trial. International journal of infectious diseases. pp. S45-S46. [Online].